| Drug Name: | Papaverine (58-74-2) |
|---|---|
| PubChem ID: | 4680 |
| SMILES: | COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC |
| InchiKey: | XQYZDYMELSJDRZ-UHFFFAOYSA-N |
| Therapeutic Category: | Cardiovascular Agents, Enzyme Inhibitors, Phosphodiesterase Inhibitors, Urological Agents, Vasodilator Agents |
| Molecular Weight (dalton) | : | 339.391 |
| LogP | : | 3.86 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 49.81 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Levodopa (59-92-7) | Parkinsonism | Antagonistic | Not understood | Antagonism of levodopa by papaverine |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category